Clinical trial
A 12-week, Randomized, Parallel-group, Phase III Study Comparing the Efficacy of Once-daily Budesonide/Formoterol Turbuhaler (160/4.5 μg/d) and Twice-daily Budesonide Giona Easyhaler (400 μg/d) During Step-down Period in Well Controlled Asthma
NCT02725242 is registered in ClinicalTrials.gov with Hat Yai Medical Education Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A 12-week, Randomized, Parallel-group, Phase III Study Comparing the Efficacy of Once-daily Budesonide/Formoterol Turbuhaler (160/4.5 μg/d) and Twice-daily Budesonide Giona Easyhaler (400 μg/d) During Step-down Period in Well Controlled Asthma
- Lead sponsor
- Hat Yai Medical Education Center
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- March 31, 2016
- Completion date
- December 31, 2016
- Enrollment
- 77 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.